Platelet Exocytosis and Endocytosis in Thrombosis and Immunity

血栓形成和免疫中的血小板胞吐作用和内吞作用

基本信息

  • 批准号:
    9894537
  • 负责人:
  • 金额:
    $ 97.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2027-03-31
  • 项目状态:
    未结题

项目摘要

Abstract Surprisingly, platelets are capable of bidirectional interactions with their microenvironment through basic cellular processes that are largely unexplored. In this R35 proposal, we expand on our active research themes: one unraveling the mechanistic role of exocytosis in hemostasis and the other investigating endocytosis as an entry pathway to define the role of platelets in innate immunity. By linking these two areas, we can gain deeper insights into how platelet interact with their microenvironments. Despite advances in understanding signaling from vascular damage detection, our view of how activated platelets execute the steps needed for clot formation is limited. We have probed the mechanisms of platelet secretion and how it affects hemostasis, using genetically altered models, and determined that modulating secretion controls thrombus growth without compromising hemostasis. To build on that advance, a better understanding of platelet exocytosis is clearly needed so logical therapeutic strategies can be developed. Our work on platelet endocytosis, endo-lysosomal trafficking, and processing of endocytosed cargo led to the discovery that platelets take up pathogens, e.g., viruses, and are activated. Increasingly, platelets are being associated with immune responses, yet the mechanisms underlying these non-hemostatic functions are largely unknown. Very little is known about platelet endocytosis and next to nothing is known about how platelets traffic and process endocytosed material. Our R35 research program seeks to fill these gaps in knowledge by taking a holistic approach to the study of platelet “cell biology”. Building on our innovative past work (>50 publications), we will further define platelet membrane trafficking (endocytosis, exocytosis, cargo sorting/processing, etc.). We hypothesize that bidirectional trafficking processes, endo- and exocytosis, are essential for platelet-specific functions, specifically thrombosis and innate immune responses. To address this hypothesis, we will examine platelet exocytosis and endocytosis at mechanistic and physiological levels using an extensive suite of reagents, transgenic mouse strains, and technologies. Going forward, we will use these powerful tools and approaches to define how platelet membrane trafficking (both exo- and endocytosis) affects hemostasis/thrombosis and immune responses at molecular and organismal levels. The data generated are directly applicable to the understanding and treatment of human disease, especially thrombotic diseases which accounts for 1 in 4 deaths world-wide and chronic viremia, e.g., AIDS/HIV1, which increases CVD risk.
摘要 令人惊讶的是,血小板能够与其微环境进行双向相互作用 通过基本的细胞过程,这些过程在很大程度上是未知的。在这份R35提案中,我们对 我们积极的研究主题:一是揭示胞吐作用在止血和 另一种是将内吞作用作为一种进入途径来确定血小板在先天性疾病中的作用。 豁免权。通过将这两个区域联系起来,我们可以更深入地了解血小板如何与 它们的微环境。尽管在理解血管损伤的信号方面取得了进展 检测,我们对激活的血小板如何执行凝块形成所需步骤的看法是 有限的。我们探讨了血小板分泌的机制及其如何影响止血, 使用基因改变的模型,并确定调节分泌控制血栓 在不影响止血的情况下增长。为了在这一进展的基础上,更好地理解 血小板胞吐显然是需要的,因此可以制定合理的治疗策略。我们的工作 关于血小板内吞、内溶酶体运输和内吞货物的处理导致 发现血小板携带病原体,如病毒,并被激活。越来越多的人, 血小板与免疫反应有关,但其背后的机制 非止血功能在很大程度上是未知的。人们对血小板内吞作用知之甚少 此外,对血小板如何运输和处理内吞物质几乎一无所知。我们的 R35研究计划寻求通过采取全面的方法来填补这些知识空白 研究血小板的“细胞生物学”。在我们过去创新工作(>50种出版物)的基础上,我们将 进一步定义血小板膜运输(内吞作用、胞吐作用、货物分类/处理, 等)。我们假设双向转运过程,即胞内和胞吐作用是必不可少的。 用于血小板特异性功能,特别是血栓形成和先天免疫反应。致信地址 在这一假说中,我们将从机制和机制上研究血小板的胞吐和内吞。 使用一套广泛的试剂、转基因小鼠品系和 技术。展望未来,我们将使用这些强大的工具和方法来定义 血小板膜转运(外吞和内吞)影响止血/血栓形成和 在分子和机体水平上的免疫反应。生成的数据直接 适用于对人类疾病,特别是血栓性疾病的认识和治疗 这占全世界四分之一的死亡和慢性病毒血症,例如艾滋病/艾滋病毒1,其中 增加心血管疾病的风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SIDNEY Waldo WHITEHEART其他文献

SIDNEY Waldo WHITEHEART的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SIDNEY Waldo WHITEHEART', 18)}}的其他基金

2022 Hemostasis Gordon Research Conference and Seminar
2022戈登止血研究会议暨研讨会
  • 批准号:
    10468359
  • 财政年份:
    2022
  • 资助金额:
    $ 97.09万
  • 项目类别:
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
血栓形成和免疫中的血小板胞吐作用和内吞作用
  • 批准号:
    10377959
  • 财政年份:
    2020
  • 资助金额:
    $ 97.09万
  • 项目类别:
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
血栓形成和免疫中的血小板胞吐作用和内吞作用
  • 批准号:
    10604325
  • 财政年份:
    2020
  • 资助金额:
    $ 97.09万
  • 项目类别:
Targeting Platelet Endocytosis and Exocytosis to Control Thrombosis
靶向血小板胞吞作用和胞吐作用来控制血栓形成
  • 批准号:
    10046272
  • 财政年份:
    2017
  • 资助金额:
    $ 97.09万
  • 项目类别:
Targeting Platelet Endocytosis and Exocytosis to Control Thrombosis
靶向血小板胞吞作用和胞吐作用来控制血栓形成
  • 批准号:
    10392316
  • 财政年份:
    2017
  • 资助金额:
    $ 97.09万
  • 项目类别:
Platelet Endocytosis in Innate Immunity
先天免疫中的血小板内吞作用
  • 批准号:
    9362971
  • 财政年份:
    2017
  • 资助金额:
    $ 97.09万
  • 项目类别:
IMAGING CORE
成像核心
  • 批准号:
    8360572
  • 财政年份:
    2011
  • 资助金额:
    $ 97.09万
  • 项目类别:
IMAGING CORE
成像核心
  • 批准号:
    8168246
  • 财政年份:
    2010
  • 资助金额:
    $ 97.09万
  • 项目类别:
KY COBRE: IMAGING CORE
KY COBRE:成像核心
  • 批准号:
    7960493
  • 财政年份:
    2009
  • 资助金额:
    $ 97.09万
  • 项目类别:
ANTIBODY PRODUCTION AND MOUSE GENOTYPING CORE
抗体生产和小鼠基因分型核心
  • 批准号:
    7960500
  • 财政年份:
    2009
  • 资助金额:
    $ 97.09万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.09万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了